Yale Cancer Genetic Counseling blog Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Thursday, April 29, 2010

Yale Cancer Genetic Counseling blog



Monday, April 19, 2010
Myriad raises price of BRCA testing, again.
On April 1, 2010 - three days after a court ruling that invalidated Myriad's patents on the BRCA1 and BRCA2 genes (associated with hereditary breast and ovarian cancer) the company increased their prices for genetic testing. Old cost =$3,770. New cost = $4,040 for full sequencing plus rearrangement testing.

0 comments :

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.